Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.07 USD | +0.10% | +17.00% | +165.35% |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
Apr. 03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+165.35% | 346M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.48% | 22.18B | |
-16.67% | 21.2B | |
-9.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Chardan Cuts Price Target on Homology Medicines to $7 From $8, Maintains Buy Rating